Literature DB >> 29716732

Different Nuss procedures and risk management for pectus excavatum after surgery for congenital heart disease.

Chenghao Chen1, Xiaofeng Li2, Na Zhang1, Jie Yu1, Dong Yan1, Changqi Xu1, Qi Zeng3, Zhongzhi Li4.   

Abstract

PURPOSE: In Nuss procedure for pectus excavatum (PE) after surgery for congenital heart disease (CHD), retrosternal adhesion may increase the risk of cardiac injury. This study aimed to explore different Nuss procedures and their implications for reducing the incidence of serious complications and improving surgical safety.
METHODS: We retrospectively reviewed 49 cases (29 male and 20 female) of Nuss procedures for PE after surgery for CHD that were performed between April 2003 and December 2016. The median age was 5.8 years (range, 3.0-17.9), and the median Haller index was 4.6 (3.2-17.7). All patients were evaluated on their cardiac function and severity of PE by echocardiography and computed tomography scan, respectively. Three surgical procedures were used. Perioperative conditions were analyzed, including CHD type, interval between two operations, blood loss, operation time, hospital stay, complications, and postoperative results.
RESULTS: All 49 cases were completed successfully. Fourteen cases (28.6%) involved the standard three-incision thoracoscopic Nuss procedure, 30 cases (61.2%) involved the Nuss procedure assisted by a median sternum incision, and 5 cases (10.2%) involved the Nuss procedure with sternal suspension. The median interval between the CHD surgery and Nuss procedure was 4.0 years (0.5-12.0). The median blood loss was 2.0 mL (1.0-150.0 mL). The median operation time was 45.0 min (27.0-230.0), and the median hospital stay was 6.0 days (5.0-9.0). Three patients (6.1%) experienced severe surgical complications: 2 experienced a rupture of the right atrium and 1 had pericardial injury. Patients were followed up for 7-120 months after surgery. The postoperative results were excellent in 46 cases (93.9%) and good in 3 (6.1%). Twenty-four of the 49 patients have had their bars removed. The median time for bar removal was 36.0 months (24.0-47.0). The outcome after bar removal surgery was excellent in 20 cases and good in 4.
CONCLUSIONS: Patients may develop PE or worsening of preexisting PE after open heart surgery for CHD. Surgery for PE can still be performed by the standard Nuss technique without increasing the risk of cardiac injury for the patients that have had interventional cardiology procedures for CHD previously. However, the risk of cardiac injury during the Nuss procedure dramatically increases due to retrosternal adhesions that develop after open heart surgery for CHD. In our experience, the Nuss procedure is safe and feasible after open heart surgery for CHD when performed by an experienced pectus surgeon using an individualized surgical plan for each patient. TYPE OF STUDY: Retrospective study. LEVEL OF EVIDENCE: Level IV.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nuss procedure; Postoperative CHD; Risk management

Mesh:

Year:  2018        PMID: 29716732     DOI: 10.1016/j.jpedsurg.2018.04.006

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Effects of repairing ventricular septal defects with right vertical infra-axillary mini-incision on lung function and postoperative analgosedation.

Authors:  Chunxiang Li; Xiaolei Gong; Jihong Huang; Limin Zhu; Wei Dong; Mingjie Zhang; Yujie Liu; Zhuoming Xu
Journal:  Exp Ther Med       Date:  2021-01-29       Impact factor: 2.447

2.  Modified Nuss procedure with a novel steel bar in patients with pectus excavatum post-congenital heart surgery.

Authors:  Siming Liu; Lei Wang; Hongkun Zhang; Wenhui Zeng; Fengqing Hu; Haibo Xiao; Guoqing Li; Ju Mei; Jiaquan Zhu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-02-21

3.  Repair of pectus excavatum in a patient with an Eloesser thoracostomy window: sequential extrapleural Nuss procedure and modified Ravitch procedure.

Authors:  Jung Wook Han; Jae Jun Kim; Won Kyu Choi; Hye Yoon Jeong; Young Eun Lee
Journal:  J Cardiothorac Surg       Date:  2022-10-17       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.